These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 7025026)

  • 1. Concurrent inhibition by tunicamycin of glycosylation and parasitemia in malarial parasites (Plasmodium falciparum) cultured in human erythrocytes.
    Udeinya IJ; Van Dyke K
    Pharmacology; 1981; 23(3):165-70. PubMed ID: 7025026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-Deoxyglucose: inhibition of parasitemia and of glucosamine incorporation into glycosylated macromolecules, in malarial parasites (Plasmodium falciparum).
    Udeinya IJ; Van Dyke K
    Pharmacology; 1981; 23(3):171-5. PubMed ID: 7025027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the effect of tunicamycin on erythrocytic stages of Plasmodium falciparum.
    Dieckmann-Schuppert A; Hensel J; Schwarz RT
    Biochem Soc Trans; 1992 May; 20(2):184S. PubMed ID: 1290509
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of malaria-infected erythrocytes by deoxyspergualin: effect on in vitro growth of malarial cultures.
    Midorikawa Y; Haque QM; Nakazawa S
    Chemotherapy; 1998; 44(6):409-13. PubMed ID: 9755301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stage-dependent toxicity of N-acetyl-glucosamine to Plasmodium falciparum.
    Gupta SK; Schulman S; Vanderberg JP
    J Protozool; 1985 Feb; 32(1):91-5. PubMed ID: 3886901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor reduces Plasmodium falciparum growth and activates calcium signaling in human malaria parasites.
    Cruz LN; Wu Y; Ulrich H; Craig AG; Garcia CR
    Biochim Biophys Acta; 2016 Jul; 1860(7):1489-97. PubMed ID: 27080559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo inhibition of erythrocytic development of malarial parasites by docetaxel.
    Sinou V; Grellier P; Schrevel J
    Antimicrob Agents Chemother; 1996 Feb; 40(2):358-61. PubMed ID: 8834880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of tunicamycin on release of macromolecules and tumor antigens by human melanoma cells.
    Johnston D; Bystryn JC
    Cancer Res; 1985 Apr; 45(4):1772-7. PubMed ID: 3978639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of neoglycoproteins on penetration of Plasmodium falciparum merozoites into erythrocytes in vitro.
    Schulman S; Lee YC; Vanderberg JP
    J Parasitol; 1984 Apr; 70(2):213-6. PubMed ID: 6381683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apparent lack of N-glycosylation in the asexual intraerythrocytic stage of Plasmodium falciparum.
    Dieckmann-Schuppert A; Bender S; Odenthal-Schnittler M; Bause E; Schwarz RT
    Eur J Biochem; 1992 Apr; 205(2):815-25. PubMed ID: 1374032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of antimalarial effect of ICL670A on in vitro cultures of Plasmodium falciparum.
    Goudeau C; Loyevsky M; Kassim OO; Gordeuk VR; Nick H
    Br J Haematol; 2001 Dec; 115(4):918-23. PubMed ID: 11843826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of mitochondrial protein synthesis inhibitors on the incorporation of isoleucine into Plasmodium falciparum in vitro.
    Blum JJ; Yayon A; Friedman S; Ginsburg H
    J Protozool; 1984 Aug; 31(3):475-9. PubMed ID: 6389849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimalarial effect of N-acetyl-L-Leucyl-L-leucyl-L-norleucinal by the inhibition of Plasmodium falciparum Calpain.
    Jung SY; Zheng B; Choi YY; Soh BY; Kim SY; Park KI; Park H
    Arch Pharm Res; 2009 Jun; 32(6):899-906. PubMed ID: 19557368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective cytotoxicity of purified homologues of tunicamycin on transformed BALB/3T3 fibroblasts.
    Seiberg M; Duksin D
    Cancer Res; 1983 Feb; 43(2):845-50. PubMed ID: 6293705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downstream effects of haemoglobinase inhibition in Plasmodium falciparum-infected erythrocytes.
    Naughton JA; Nasizadeh S; Bell A
    Mol Biochem Parasitol; 2010 Oct; 173(2):81-7. PubMed ID: 20478341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The treatment of Plasmodium falciparum-infected erythrocytes with chloroquine leads to accumulation of ferriprotoporphyrin IX bound to particular parasite proteins and to the inhibition of the parasite's 6-phosphogluconate dehydrogenase.
    Famin O; Ginsburg H
    Parasite; 2003 Mar; 10(1):39-50. PubMed ID: 12669348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent inhibitors of Plasmodium phospholipid metabolism with a broad spectrum of in vitro antimalarial activities.
    Ancelin ML; Calas M; Vidal-Sailhan V; Herbuté S; Ringwald P; Vial HJ
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2590-7. PubMed ID: 12878524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of the antimalarial microtubule inhibitors trifluralin and vinblastine by Plasmodium falciparum.
    Naughton JA; Hughes R; Bray P; Bell A
    Biochem Pharmacol; 2008 Apr; 75(8):1580-7. PubMed ID: 18291349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of glycosylated beta-amino hydroxamates as new class of antimalarials.
    Mishra RC; Tripathi R; Katiyar D; Tewari N; Singh D; Tripathi RP
    Bioorg Med Chem; 2003 Dec; 11(24):5363-74. PubMed ID: 14642580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of malaria parasite Plasmodium falciparum development by crotamine, a cell penetrating peptide from the snake venom.
    El Chamy Maluf S; Dal Mas C; Oliveira EB; Melo PM; Carmona AK; Gazarini ML; Hayashi MA
    Peptides; 2016 Apr; 78():11-6. PubMed ID: 26806200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.